August 09,2007
Grassley Seeks FDA Briefing on Steps to Ensure Safety of Foreign-made Medicine
WASHINGTON – Sen. Chuck Grassley, ranking member of the Committee on Finance, is asking the Food and Drug Administration for an explanation of its steps to ensure the safety of foreign-made medicine. In a letter to the agency commissioner, Grassley said he is disturbed by reports of the inadequacy of FDA inspections of foreign pharmaceutical manufacturing facilities, especially given the growing predominance of overseas manufacturing of such products.
The text of Grassley’s letter follows here.
###
Next Article Previous Article
Recent News
- Wyden Statement on House Passage of Reconciliation Legislation
- Wyden Warns Republicans that Overruling Parliamentarian to Nix California Clean Air Waiver Will Backfire
- Wyden Statement on IRS Nominee Billy Long's Involvement in Tax Scams
- Wyden Opposes HHS Nominees O'Neill and Andres to be Deputy Secretary and Congressional Liaison
- Wyden Blasts Trump's Tariff War Threatening Global Supply Chains at Finance Committee Hearing